Literature DB >> 23392840

[Anti-VEGF therapy in neovascular age-related macular degeneration: therapeutic strategies].

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23392840     DOI： 10.1007/s00347-013-2788-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  5 in total

1.  [Statement of the Deutsche Ophthalmologische Gesellschaft (German Ophthalmological Society), the Retinologische Gesellschaft (German Retina Society) and the Berufsverband der Augenärzte Deutschlands (German Professional Association of Ophthalmologists) on the therapy of choroidal neovascularization in myopia. State: March 2014].

Authors:  D Pauleikhoff; B Bertram; D Claessens
Journal:  Ophthalmologe       Date:  2014-03       Impact factor: 1.059

2.  [Change of therapy from ranibizumab to aflibercept for recurrent or persistent exudative age-related macular degeneration].

Authors:  M Ziegler; B Heimes; B Book; M Dietzel; M Zeimer; G Spital; M Gutfleisch; D Pauleikhoff; A Lommatzsch
Journal:  Ophthalmologe       Date:  2015-05       Impact factor: 1.059

3.  [Delayed treatment initiation of more than 2 weeks. Relevance for possible gain of visual acuity after anti-VEGF therapy under real life conditions (interim analysis of the prospective OCEAN study)].

Authors:  F Ziemssen; T Bertelmann; U Hufenbach; M Scheffler; S Liakopoulos; S Schmitz-Valckenberg
Journal:  Ophthalmologe       Date:  2016-02       Impact factor: 1.059

4.  [Increase in examinations for cataracts, glaucoma, diabetic retinopathy and age-related macular degeneration : Comparative cross-sectional study between 2010 and 1997 in ophthalmological practices].

Authors:  B Bertram; C Gante; R-D Hilgers
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

5.  [Baseline diagnostics and initial treatment decision for anti-vascular endothelial growth factor treatment in retinal diseases : Comparison between results by study physician and reading centers (ORCA/OCEAN study)].

Authors:  Christian K Brinkmann; Petrus Chang; Tina Schick; Britta Heimes; Jessica Vögeler; Birgit Haegele; Bernd Kirchhof; Frank G Holz; Daniel Pauleikhoff; Focke Ziemssen; Sandra Liakopoulos; Georg Spital; Steffen Schmitz-Valckenberg
Journal:  Ophthalmologe       Date:  2019-08       Impact factor: 1.059
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.